LESLIE MENCHETTI: Open Payments
NPI 1083654677 · ORLAND, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,581 in 57 payments from 16 companies in 2025. Trend: 2023 $1,608 · 2024 $1,223 · 2025 $1,581
Food & beverage: $1,581
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $329 |
| Novo Nordisk Inc | 10 | $308 |
| AstraZeneca Pharmaceuticals LP | 3 | $244 |
| PFIZER INC. | 4 | $188 |
| GlaxoSmithKline, LLC. | 1 | $104 |
| Optinose US, Inc. | 1 | $98 |
| Amgen Inc. | 3 | $85 |
| Exact Sciences Corporation | 2 | $35 |
| Agios Pharmaceuticals, Inc. | 1 | $33 |
| Tandem Diabetes Care, Inc. | 2 | $31 |
Products named: UBRELVY, Ozempic, BREZTRI, QULIPTA, Wegovy, COMIRNATY, TEZSPIRE, AREXVY.
Industry payments across CA — which companies pay providers there.
